A phase II trial of BLD-2660 in patients with liver fibrosis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 27 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 Sep 2019 According to a Blade Therapeutics media release, the company plans to submit the IND application to the U.S. FDA and initiate the Phase II trial of BLD-2660 by early 2020.
01 Aug 2019 New trial record
31 Jul 2019 According to a Blade Therapeutics media release, the company will submit an Investigational New Drug (IND) application to the U.S. FDA to initiate a Phase II trial of BLD-2660 in patients with liver fibrosis by year-end 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com